Alopecia, Androgenetic Clinical Trial
Official title:
Role of Vitamin D in Androgenetic Alopecia
Androgenetic alopecia is a common form of diffuse hair loss in both men and women,It primarily affects the top and front of the scalp with different clinical presentations and there are numerous classification systems for grading purposes.
These systems vary from the simple systems based on recession of the hairline to more
advanced multifactorial systems based on morphological and dynamic parameters that affect the
scalp and hair. Most of these systems have certain limitations. Currently, the most commonly
used are Hamilton- Norwood classification system for males where there are two areas of hair
loss that gradually enlarge to produce recession at the temples and thinning in the crown.
These regions coalesce until the entire front, top and crown (vertex) of the scalp are bald(2
major pattern,7 grades) and the Ludwig system for females which classify the Female Pattern
Hair Loss into three grades depending on the reduction in hair density over the crown and
frontal scalp with retention of the frontal hairline.
Etiopathogenesis of Androgenetic Alopecia has not yet been fully elucidated. Genetic factors,
hair follicle cycle abnormalities, aging process and androgen dependent process including end
organ sensitivity have been all incriminated as etiological factors .
Dermoscopy has emerged as an useful tool in the diagnosis of hair loss disorder including
Androgenetic Alopecia. Important features of Androgenetic Alopecia on Dermoscopy include hair
shaft thickness heterogeneity, yellow dots (irregularly distributed and with a remarkable
variability in size and shape), perifollicular discolouration (the peripilar sign), an
increased proportion of thin and vellus hairs (>10 % of the hairs) and a large number of
follicular units with only one emerging hair shaft. Thin wavy hair and honeycomb
hyperpigmentation often coexist as additional, nonspecific features Vitamin D is a
secosteroid hormone that plays an important role in calcium homeostasis and bone health. It
has three sources: endogenous synthesis in the skin, which is induced by Ultraviolet B
radiation; dietary intake; and supplementation .
Basically, Vitamin D is a modulator of both innate and adaptive immune systems through its
various effects on T and B lymphocytes, dendritic cells and macrophages. There is a
well-established causal connection between vitamin D deficiency and some autoimmune diseases
, and possible association with some hair disorders, as it has been demonstrated that vitamin
D receptors are strongly expressed in hair follicles and keratinocytes. Such an expression
was found to be necessary for maintenance of the normal hair cycle. Also, it has also been
shown that lack of vitamin D receptors reduces epidermal differentiation and hair follicle
growth, and that an optimum concentration of Vitamin D3 is essential to delay aging and hair
loss.
Several studies were done to evaluate the role of vitamin D in different hair disorders with
contrasting results. Some studies revealed low serum levels of Vitamin D in women with
chronic telogen effluvium,Female Pattern Hair Loss and Alopecia Areata.While, two studies
showed no correlation between the extent and severity of male androgenetic alopecia with
serum Vitamin D3 level.
Based on the above contrasting reports, we sought to evaluate the levels of Vitamin D in
patients with androgenetic alopecia in order to establish its possible role in the
etiopathogenesis and hence in the treatment of such a common and chronic hair disorder
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01189279 -
Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia
|
Phase 1 | |
Completed |
NCT05296863 -
Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia
|
Phase 3 | |
Completed |
NCT02503852 -
STYLE -- A Trial of Cell Enriched Adipose For Androgenetic Alopecia
|
N/A | |
Completed |
NCT05802173 -
Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia
|
Phase 2 | |
Terminated |
NCT02676310 -
Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
|
Phase 1 | |
Recruiting |
NCT05910450 -
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
|
Phase 3 | |
Completed |
NCT01325337 -
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
|
Phase 2 | |
Not yet recruiting |
NCT02316418 -
Hairstetics™ Anchoring System in Female Pattern Hair Loss (HAS-FPHL)
|
N/A | |
Recruiting |
NCT06263413 -
Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions
|
||
Recruiting |
NCT05681897 -
Comparing Platelet-Rich Plasma (PRP) Centrifugation Methods on Thrombocyte Concentration and Clinical Improvement of Androgenetic Alopecia
|
N/A | |
Completed |
NCT05244980 -
A Study of TDM-105795 in Male Subjects With Androgenetic Alopecia (AGA)
|
Phase 1 | |
Completed |
NCT01904721 -
A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA)
|
Phase 2 | |
Completed |
NCT03004469 -
Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia
|
Phase 3 | |
Recruiting |
NCT05914805 -
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)
|
Phase 3 | |
Completed |
NCT04913519 -
A Phase 1 Study of TDM-105795 Topical Solution in Male Subjects With Androgenetic Alopecia (AGA)
|
Phase 1 |